J&C Healthcare Ltd 31/12/2024 iXBRL

Company registration number: 13310214

J&C Healthcare Ltd

Unaudited filleted financial statements

31 December 2024

J&C Healthcare Ltd

Contents

Directors and other information

Statement of financial position

Notes to the financial statements

J&C Healthcare Ltd

Directors and other information


	Directors	D R Bowley-Farleigh
		J Bowley-Farleigh


	Company number	13310214


	Registered office	47 Mutley Plain
		Plymouth
		Devon
		PL4 6JQ


	Accountants	Franklins Accountants LLP
		Astor House
		2 Alexandra Road
		Mutley Plain
		Pymouth
		PL4 7JR

J&C Healthcare Ltd

Statement of financial position

31 December 2024

		2024		2023
	Note	£	£	£	£

Fixed assets
Tangible assets	6	141,189		114,069
		_______		_______
			141,189		114,069

Current assets
Debtors	7	262,880		94,560
Cash at bank and in hand		181,816		150,423
		_______		_______
		444,696		244,983
Creditors: amounts falling due
within one year	8	( 352,293)		( 198,090)
		_______		_______
Net current assets			92,403		46,893
			_______		_______
Total assets less current liabilities			233,592		160,962

Creditors: amounts falling due
after more than one year	9		( 220,706)		-

Provisions for liabilities			( 6,483)		( 13,660)

			_______		_______
Net assets			6,403		147,302
			_______		_______

Capital and reserves
Called up share capital			4		4
Profit and loss account			6,399		147,298
			_______		_______
Shareholders funds			6,403		147,302
			_______		_______

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 26 September 2025 , and are signed on behalf of the board by:

J Bowley-Farleigh

Director

Company registration number: 13310214

J&C Healthcare Ltd

Notes to the financial statements

Year ended 31 December 2024

1. General information

The company is a private company limited by shares, registered in England. The address of the registered office is 47 Mutley Plain, Plymouth, Devon, PL4 6JQ.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:


Short leasehold property	-	20 %	straight line
Fittings fixtures and equipment	-	25 %	reducing balance
Motor vehicles	-	25 %	reducing balance

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 91 (2023: 61 ).

5. Tax on loss/profit

Major components of tax income/expense

	2024	2023
	£	£
Current tax:
UK current tax expense	-	52,465
	_______	_______

Deferred tax:
Origination and reversal of timing differences	( 7,177)	9,580
	_______	_______
Tax on loss/profit	( 7,177)	62,045
	_______	_______

6. Tangible assets

	Short leasehold property	Fixtures, fittings and equipment	Motor vehicles	Total
	£	£	£	£
Cost
At 1 January 2024	19,313	40,250	96,527	156,090
Additions	14,961	24,357	78,476	117,794
Disposals	( 19,313)	-	( 70,732)	( 90,045)
	_______	_______	_______	_______
At 31 December 2024	14,961	64,607	104,271	183,839
	_______	_______	_______	_______
Depreciation
At 1 January 2024	4,882	12,209	24,930	42,021
Charge for the year	2,137	13,099	6,947	22,183
Disposals	( 4,882)	-	( 16,672)	( 21,554)
	_______	_______	_______	_______
At 31 December 2024	2,137	25,308	15,205	42,650
	_______	_______	_______	_______
Carrying amount
At 31 December 2024	12,824	39,299	89,066	141,189
	_______	_______	_______	_______
At 31 December 2023	14,431	28,041	71,597	114,069
	_______	_______	_______	_______

7. Debtors

	2024	2023
	£	£
Trade debtors	57,702	88,512
Other debtors	205,178	6,048
	_______	_______
	262,880	94,560
	_______	_______

8. Creditors: amounts falling due within one year

	2024	2023
	£	£
Bank loans and overdrafts	204,721	51,458
Corporation tax	-	52,367
Social security and other taxes	21,171	13,198
Other creditors	126,401	81,067
	_______	_______
	352,293	198,090
	_______	_______

9. Creditors: amounts falling due after more than one year

	2024	2023
	£	£
Bank loans and overdrafts	168,880	-
Other creditors	51,826	-
	_______	_______
	220,706	-
	_______	_______

10. Operating leases

The company as lessee

The total future minimum lease payments under non-cancellable operating leases are as follows:


	£	£

Not later than 1 year	23,400	3,432
Later than 1 year and not later than 5 years	93,600	4,862
Later than 5 years	29,250	-
	_______	_______
	146,250	8,294
	_______	_______

11. Directors advances, credits and guarantees

	During the year the directors entered into the following advances and credits with the company:

2024
		Balance brought forward	Advances /(credits) to the directors	Amounts repaid	Balance o/standing
		£	£	£	£
	D R Bowley-Farleigh	( 751)	148,491	( 50,000)	97,740
	J Bowley-Farleigh	( 751)	148,491	( 50,000)	97,740
		_______	_______	_______	_______
		( 1,502)	296,982	( 100,000)	195,480
		_______	_______	_______	_______

2023
		Balance brought forward	Advances /(credits) to the directors	Amounts repaid	Balance o/standing
		£	£	£	£
	D R Bowley-Farleigh	( 1,409)	75,658	( 75,000)	( 751)
	J Bowley-Farleigh	( 1,409)	75,658	( 75,000)	( 751)
		_______	_______	_______	_______
		( 2,818)	151,316	( 150,000)	( 1,502)
		_______	_______	_______	_______

Mr J and Mr D Bowley-Farleigh (directors and shareholders) owe the company £195,480 at 31 December 2024. This loan is repayable on demand and interest is being charged at the official rate of interest. During the year dividends of £100,000 (2023 - £150,000) and rent of £7,500 (2023 - £13, 500) was paid to Mr J and Mr D Bowley-Farleigh.

12. Controlling party

The company is controlled by Mr D and Mr J Bowley-Farleigh by virtue of thier directorships and shareholding.